Granulocyte phagocytic function is impaired during cardiopulmonary bypass

Annals of Thoracic Surgery

Volumn 62, Issue 6, 1996, Pages 1820-1824

  Hamano, Kimikazu ^a,b   Ito, Hiroshi ^a   Katoh, Tomoe ^a   Fujimura, Yoshihiko ^a   Tsuboi, Hidetoshi ^a   Esato, Kensuke ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA ANEURYSM; ARTICLE; CARDIOPULMONARY BYPASS; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; MALE; PHAGOCYTOSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

AGED; AORTIC ANEURYSM, ABDOMINAL; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHEMILUMINESCENT MEASUREMENTS; FEMALE; GRANULOCYTES; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; PHAGOCYTOSIS;

EID: 0030551290     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)00680-7     Document Type: Article

References (21)

1. 1. Chenoweth DE, Cooper SW, Hugli TE, et al. Complement activation during cardiopulmonary bypass. N Engl J Med 1981;304:497-503.
2. 2. Kusserow B, Larrow R, Nicols J. Perfusion and surface-induced injury in leukocytes. Fed Proc 1971;30:1516-20.
3. 3. Tajima K, Yamanoto F, Kawazoe K, et al. Cardiopulmonary bypass and cellular immunity: changes in lymphocyte subsets and natural killer cell activity. Ann Thorac Surg 1993;55: 625-30.
4. 4. Van Velzen-Blad H, Dijkstra YJ, Schurink GA, et al. Cardiopulmonary bypass and host defence functions in human beings: I. Serum levels and role of immunoglobulins and complement in phagocytosis. Ann Thorac Surg 1985;39: 207-11.
5. 5. Silva J Jr, Hoeksema H, Fekety FR Jr. Transient defects in phagocytic functions during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1973;67:175-83.
6. 6. Schildt B, Berghem L, Holm G, et al. Influence of cardiopulmonary bypass on some host defense functions in man. Scand J Thorac Cardiovasc Surg 1980;14:207-11.
7. 7. Shimono T, Nose Y, Yada I, et al. Is it true that cardiac operations with cardiopulmonary bypass impair the reticuloendothelial system? Ann Thorac Surg 1994;58:1059-63.
8. 8. Tono-Oka T, Ueno N, Matsumoto T, Ohkawa M, Matsumoto S. Chemiluminescence of whole blood. Clin Immunol Immunopathol 1983;26:66-75.
9. 9. English D, Andersen BR. Single-step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradient of Ficoll Hypaque. J Immunol Methods 1974;5:249-52.
10. 10. Yamaguchi K, Fujikura Y, Kuniki H, et al. Immunoelectron microscopic localization of cell surface antigens on rat hepatocytes detected with monoclonal antibodies (HAM2 and HAM4). Cell Struct Funct 1991;16:303-13.
11. 11. Snyder EL, Barash PG, Mosher DF, Walter SD. Plasma fibronectin level and clinical status in cardiac surgery patients. J Lab Clin Med 1983;102:881-9.
12. 12. Pourrat E, Sie PM, Desrez X, et al. Changes in plasma fibronectin levels after cardiac and pulmonary surgery: role of cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg 1985;19:63-7.
13. 13. Charash WE, Foster ED, Saba TM, Dayton C, Cho E. Plasma fibronectin levels during cardiopulmonary bypass. J Appl Physiol 1990;69:1644-50.
14. 14. Subramanian V, McLeod J, Gans H. Effect of extracorporeal circulation on reticuloendothelial function. I. Experimental evidence for impaired reticuloendotherial function following cardiopulmonary bypass in rats. Surgery 1968;64:775-84.
15. 15. Cruickshank AH. Inflammation. In: McFarland J, ed. Basic clinical surgery for nurses and medical students. 2nd ed. London: Butterworths, 1980:161-78.
16. 16. Kirklin JW, Barratt-Boyes BG, ed. Cardiac surgery. 2nd ed. New York: Churchill Livingstone, 1993:85-9.
17. 17. Moore PL, Bank HL, Brissie NT, Spicer SS. Phagocytosis of bacteria by polymorphonuclear leukocytes. J Cell Biol 1978; 76:158-74.
18. 18. Tokunaga M, Tokunaga J, Niimi M. Leukocyte and macrophage movements under phagocytosis. In: Tanaka K, Fujita T, eds. Scanning electron microscopy in cell biology and medicine. Amsterdam: Excerpta Medica, 1981:13-22.
19. 19. Riegel W, Spillner G, Schlosser V, Horl W. Plasma levels of main granulocyte components during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1988;95:1014-9.
20. 20. Benetti FJ, Naselli G, Wood M, et al. Direct coronary artery surgery with saphenous bypass without either cardiopulmonary bypass or cardiac arrest. J Cardiovasc Surg 1985;26: 217-22.
21. 21. Pfister AJ, Zaki MS, Garcia JM, et al. Coronary artery bypass without cardiopulmonary bypass. Ann Thorac Surg 1992;54: 1085-92.